In this study, we evaluated new vascular network parameters difficult to assess with conventional immunohistochemistry in patients with clinically staged T3 primary colorectal carcinoma, without metastatic spread, by using CLE combined with fluorescently labeled anti-CD31 antibodies for labeling of both normal and tumor blood vessels. The gene discussed is PECAM1; the disease is colorectal carcinoma.